RS

Ramani Sushant Khanvilkar

Active Director Director DIN 11106405
DIN 11106405 First appointment May 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramani Sushant Khanvilkar

Data last updated:

Ramani Sushant Khanvilkar is a Director at Microedge Medical Private Limited (since 2025). The company operates in Healthcare.

DIN 11106405
Primary Designation Director
Industry Healthcare
First Appointment 14 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Microedge Medical Private Limited U47720MH2025PTC448273
Director14 May 20252025Active

Board colleagues of Ramani Sushant Khanvilkar

Directorship timeline

Open interactive timeline →
Microedge Medical Private Limited
Premium access

Shareholding and investment profile for Ramani Sushant Khanvilkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramani Sushant Khanvilkar

Ramani Sushant Khanvilkar currently holds 1 directorship: Microedge Medical Private Limited (Director, since 14 May 2025).

Ramani Sushant Khanvilkar was first appointed on 14 May 2025 as Director at Microedge Medical Private Limited.

The current boards of Ramani Sushant Khanvilkar's companies include Ruchita Vikas Ravirala (Microedge Medical Private Limited), Sayali Santosh Muddalkar (Microedge Medical Private Limited), Varsha Gupta (Microedge Medical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available